| CLIN |
PATH |
DEFINITIONS |
| |
|
PRIMARY TUMOR (T) |
|
|
|
TX |
Primary tumor cannot be assessed |
|
|
|
T0 |
No evidence of primary tumor |
|
|
|
T1 |
Tumor 2.5 cm or less in greatest dimension limited to the lacrimal gland and mobile within the lacrimal fossa |
|
|
|
T2 |
Tumor 2.5 or less in greatest dimension invading the periosteum of the fossa of the lacrimal gland |
|
|
|
T3 |
Tumor more than 2.5 cm but not more than 5 cm in greatest dimension |
|
|
|
|
T3a |
Tumor limited to the lacrimal gland |
|
|
|
|
T3b |
Tumor invades the periosteum of the fossa of the lacrimal glands |
|
|
|
T4 |
Tumor more than 5 cm in greatest dimension |
|
|
|
|
T4a |
With invasion of orbital soft tissues, optic nerve, or globe, without bone invasion |
|
|
|
|
T4b |
With invasion of orbital soft tissues, optic nerve, or globe, with bone invasion |
| |
|
LYMPH
NODE (N) |
|
|
|
NX |
Regional lymph nodes cannot
be assessed |
|
|
|
N0 |
No regional lymph node
metastasis |
|
|
|
N1 |
Regional lymph node metastasis |
| |
|
DISTANT METASTASIS (M) |
|
|
|
MX |
Presence of distant metastasis cannot be assessed |
|
|
|
M0 |
No distant metastasis |
|
|
|
M1 |
Distast metastasis |